Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Honing In On Value At Citicorp Healthcare Conference

Executive Summary

The value of medicine was a key theme at Citigroup’s Global Healthcare conference in New York, where top executives from Bristol, Sanofi, Pfizer and Lilly, including J&J’s CEO Alex Gorsky participated in Q&As with analysts and attendees.

You may also be interested in...



Many New Oncology Drugs In 2012, With Prices That Test The Limits

More than a dozen new molecular entities launched for the treatment of cancer in 2012, advancing care for seriously ill people, but many carry price tags of $100,000 per year or more for treatment, escalating debate over cost of care and how best to direct limited healthcare resources.

Cancer Pathways Will Help Inform Drug Performance Measures, Payers Say

Over the last two years, UnitedHealthcare and Aetna have launched cancer pathway programs with the overall goals of standardizing and improving care and lowering cost. Drug therapy is a key focus.

Looking Ahead To 2012: ACOs Get In Gear, Accelerating The Need to Prove Biopharma Products' Overall Value In Health Care

Thirty-two "Pioneer" accountable care organizations began operations with the new year.

Topics

UsernamePublicRestriction

Register

PS055158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel